Skip to main content
. 2022 Jan 24;8:797890. doi: 10.3389/fmed.2021.797890

Figure 3.

Figure 3

Forest plots depicting the standardized mean difference (SMD) of Melasma Area and Severity Index (MASI) reduction in patients with melasma receiving botanical products in placebo-controlled trials. Subgroup analysis was stratified according to the duration of the intervention.